Bristol-Myers Squibb Company (BMY) FY Conference Transcript
Bristol-Myers Squibb Company (BMY) FY Conference June 11, 2025 10:00 AM ET Speaker0 All right. We're just right about at time. So let's get started. Welcome to day three of our Healthcare Conference. My name is Assad Haidar. I'm The U. S. Pharmaceutical Analyst here at Goldman Sachs. I'm very, very pleased and privileged to have the Bristol Myers team over here, Chris Boerner, Chairman and CEO and Adam Wenkowski, Chief Commercial Officer. Chris and Adam, welcome, and thank you for being with us. It's great ...